Trailing-twelve-month (TTM) revenue is $434.96 Million with a year-over-year growth of +9.46%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $86,461,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $134,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q1 FY2026Period ended 2026-03-31 | $98,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $115,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $434,961,000 |
Current P/S: $1,807,292,469 market capitalization ÷ $434,961,000 TTM revenue = 4.16x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $115.90M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:57:49.120Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Advisory and Other Ancillary Fees | $731,000 | $4M | $3M | $10M |
| Incentive Fees | $5M | N/A | N/A | N/A |
| Management Fees | $145M | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| BRAZIL | $26M | $40M | $50M | $70M |
| CAYMAN ISLANDS | $201M | $160M | $215M | $169M |
| CHILE | $5M | $52M | $53M | $40M |
$434.96M
$434.96 Million
+9.46%
vs. $397.37M a year ago (TTM)
+15.19%
5 Year compound annual growth rate
1 Year
+9.46%
3 Year
+13.10%
5 Year
+15.19%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $383.80M | +$9.60M | +2.56% |
| 2024 | $374.20M | +$46.59M | +14.22% |
| 2023 | $327.62M | +$68.74M | +26.55% |
| 2022 | $258.88M | +$23.36M | +9.92% |
| 2021 | $235.51M | +$120.50M | +104.77% |
| 2020 |
TTM Growth
+9.46%
3-Year CAGR
+13.10%
5-Year CAGR
+15.19%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 23 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| Performance Fees | $89M | N/A | N/A | N/A |
|---|
| Total Fund Fees | $239M | N/A | N/A | N/A |
|---|
| COLOMBIA |
|---|
| N/A |
| N/A |
| $2M |
| $19M |
| UNITED STATES | $2M | $3M | $4M | $3M |
|---|
| URUGUAY | N/A | N/A | $2M | $3M |
|---|
| VIRGIN ISLANDS, BRITISH | $2M | $3M | $23,000 | N/A |
|---|
| $115.02M |
| ($8.47M) |
| (6.86%) |
| 2019 | $123.48M | +$17.82M | +16.86% |
